The strongest consistent signal across population groups was the higher proportion of GPNMB+ microglia in individuals with a clinical diagnosis of Alzheimer’s dementia and/or steeper slope of cognitive decline; this signal was found in all three brain regions (Fig. 1F). Here, GPNMB is linked to Alzheimer disease.